NCT01221870 - Tesetaxel as First-line Therapy for Metastatic Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

October 31, 2012

Study Completion Date

January 31, 2013

Conditions

Breast Neoplasm

Interventions

DRUG

Tesetaxel once every 3 weeks

Tesetaxel capsules orally once every 21 days; duration of therapy not to exceed 12 months

DRUG

Tesetaxel once weekly

Tesetaxel capsules orally once every 7 days for 3 consecutive weeks in a 28-day cycle; duration of therapy not to exceed 12 months

Trial Locations (4)

RECRUITING

Memorial Sloan-Kettering Cancer Center, New York

RECRUITING

The Moses H. Cone Regional Cancer Center, Greensboro

ACTIVE_NOT_RECRUITING

The West Clinic, Memphis

RECRUITING

Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas